Terms: = Leukemia AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Clinical Outcome
956 results:
1. Similar Survival But Less Chronic GVHD in Antithymocyte Globulin-Based Myeloablative Haploidentical Transplant Compared With Matched Sibling Transplant for Adult T-cell Acute Lymphoblastic leukemia/Lymphoma.
Gu Z; Li F; Li M; Zhang L; Xu S; Wang L; Wang L; Jing Y; Bo J; Gao C; Dou L; Liu D
Cell Transplant; 2024; 33():9636897241270401. PubMed ID: 39219184
[TBL] [Abstract] [Full Text] [Related]
2. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).
Weichenhan D; Riedel A; Sollier E; Toprak UH; Hey J; Breuer K; Wierzbinska JA; Touzart A; Lutsik P; Bähr M; Östlund A; Nilsson T; Jacobsson S; Edler M; Waraky A; Behrens YL; Göhring G; Schlegelberger B; Steinek C; Harz H; Leonhardt H; Dolnik A; Reinhardt D; Bullinger L; Palmqvist L; Lipka DB; Plass C
Blood Adv; 2024 Oct; 8(19):5100-5111. PubMed ID: 39121370
[TBL] [Abstract] [Full Text] [Related]
3. New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.
Cadot S; Audebert C; Dion C; Ken S; Dupré L; Largeaud L; Laurent C; Ysebaert L; Crauste F; Quillet-Mary A
PLoS Med; 2024 Jul; 21(7):e1004430. PubMed ID: 39037964
[TBL] [Abstract] [Full Text] [Related]
4. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).
Galieni P; Troiani E; Picardi P; Angelini M; Mestichelli F; Dalsass A; Maravalle D; Camaioni E; Bigazzi C; Caraffa P; Ruggieri M; Mazzotta S; Mattioli S; Angelini S
Leuk Res; 2024 Aug; 143():107541. PubMed ID: 38905908
[TBL] [Abstract] [Full Text] [Related]
5. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Labrador J; Martínez-Cuadrón D; Boluda B; Serrano J; Gil C; Pérez-Simón JA; Bernal T; Bergua JM; Martínez-López J; Rodríguez-Medina C; Vidriales MB; García-Boyero R; Algarra L; Polo M; Sayas MJ; Tormo M; Alonso-Domínguez JM; Herrera P; Lavilla E; Ramos F; Amigo ML; Vives-Polo S; Rodríguez-Macías G; Mena-Durán A; Pérez-Encinas MM; Arce-Fernández O; Cuello R; Sánchez-García J; Gómez-Casares MT; Chillón MC; Calasanz MJ; Ayala R; Rodriguez-Veiga R; Barragán E; Montesinos P;
Cancer; 2024 Oct; 130(20):3436-3451. PubMed ID: 38896056
[TBL] [Abstract] [Full Text] [Related]
6. High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.
Zhang Z; Fu C; Sun Y; Liu Y; Wang Q; Yan W; Wu C; Wang Q; Zeng Z; Wen L; Shen H; Yao L; Liu D; Chen S; Pan J
Ann Hematol; 2024 Jul; 103(7):2337-2346. PubMed ID: 38849603
[TBL] [Abstract] [Full Text] [Related]
7. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Neumann M; Beder T; Bastian L; Hänzelmann S; Bultmann M; Wolgast N; Hartmann A; Trautmann H; Ortiz-Tanchez J; Schlee C; Schroeder M; Fransecky L; Vosberg S; Fiedler W; Alakel N; Heberling L; Kondakci M; Starck M; Schwartz S; Raffel S; Müller-Tidow C; Schneller F; Reichle A; Burmeister T; Greif PA; Brüggemann M; Gökbuget N; Baldus CD
Leukemia; 2024 Jun; 38(6):1213-1222. PubMed ID: 38744920
[TBL] [Abstract] [Full Text] [Related]
8. Anti-T-lymphocyte globulin exposure is associated with acute graft-
Oostenbrink LVE; Von Asmuth EGJ; Jol-van der Zijde CM; Jansen-Hoogendijk AM; Vervat C; Bredius RGM; Van Tol MJD; Schilham MW; Sedlacek P; Ifversen M; Balduzzi A; Bader P; Peters C; Moes DJAR; Lankester AC
Haematologica; 2024 Sep; 109(9):2854-2863. PubMed ID: 38721739
[TBL] [Abstract] [Full Text] [Related]
9. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
10. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; Hänel M; Dierlamm J; Pott C; Klapper W; Gözel D; Schmidt C; Unterhalt M; Ladetto M; Hoster E
Lancet; 2024 May; 403(10441):2293-2306. PubMed ID: 38705160
[TBL] [Abstract] [Full Text] [Related]
11. Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid leukemia.
Dillon LW; Gui G; Ravindra N; Andrew G; Mukherjee D; Wong ZC; Huang Y; Gerhold J; Holman M; D'Angelo J; Miller J; Higgins J; Salk JJ; Auletta JJ; El Chaer F; Devine SM; Jimenez-Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Spellman SR; Zeger SL; Page KM; Hourigan CS
JAMA Oncol; 2024 Aug; 10(8):1104-1110. PubMed ID: 38696205
[TBL] [Abstract] [Full Text] [Related]
12. Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes.
Panda T; Rainchwar S; Singh R; Singh A; Soni M; Kakkar D; Jegan KR; Pillai RH; Palatty RJ; Jha K; Ahmed R; Halder R; Tejwani N; Panda D; Bhurani D; Agrawal N
Leuk Res; 2024 Jun; 141():107506. PubMed ID: 38663165
[TBL] [Abstract] [Full Text] [Related]
13. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
[TBL] [Abstract] [Full Text] [Related]
14. Non-cancerous complications in HTLV-1 carriers.
Ohmoto A; Fuji S
Expert Rev Anti Infect Ther; 2024 May; 22(5):307-316. PubMed ID: 38536666
[TBL] [Abstract] [Full Text] [Related]
15. clinical Analysis of Pediatric Acute Megakaryocytic leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract] [Full Text] [Related]
16. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid leukemia.
Zhai Y; Shen H; Wei H
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
[TBL] [Abstract] [Full Text] [Related]
17. Patient-Specific Measurable Residual Disease Markers Predict outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Tobiasson M; Pandzic T; Illman J; Nilsson L; Weström S; Ejerblad E; Olesen G; Björklund A; Olsnes Kittang A; Werlenius O; Lorentz F; Rasmussen B; Cammenga J; Weber D; Lindholm C; Wiggh J; Dimitriou M; Moen AE; Yip Lundström L; von Bahr L; Baltzer-Sollander K; Jädersten M; Kytölä S; Walldin G; Ljungman P; Groenbaek K; Mielke S; Jacobsen SEW; Ebeling F; Cavelier L; Smidstrup Friis L; Dybedal I; Hellström-Lindberg E
J Clin Oncol; 2024 Apr; 42(12):1378-1390. PubMed ID: 38232336
[TBL] [Abstract] [Full Text] [Related]
18. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Abdelbaky SB; Giacopelli B; Rabe KG; Yamaguchi K; Wu YZ; Yan H; Shanafelt TD; Parikh SA; Ding W; Hampel PJ; Brown S; Cerhan JR; Vachon CM; Kay NE; Hanson CA; Parker AS; Braggio E; Slager SL; Oakes CC
Blood; 2024 Apr; 143(17):1752-1757. PubMed ID: 38194687
[TBL] [Abstract] [Full Text] [Related]
20. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L;
J Pathol; 2024 Mar; 262(3):255-270. PubMed ID: 38180354
[TBL] [Abstract] [Full Text] [Related]
[Next]